Search clinical trials for: Poziotinib Hydrochloride
Total 7342 results
-
M.D. Anderson Cancer CenterWithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8
-
Hanmi Pharmaceutical Company LimitedCompletedMetastatic Breast CancerKorea, Republic of
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Spectrum Pharmaceuticals, IncCompletedBreast CancerUnited States
-
Samsung Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | NSCLCUnited States
-
Korean Association for the Study of Targeted TherapyChonnam National University Hospital; Kyungpook National University Hospital; Konkuk University Medical Center and other collaboratorsCompletedHER2 Gene Mutation | Adenocarcinoma Lung Stage IVKorea, Republic of
-
Spectrum Pharmaceuticals, IncCompleted
-
National OncoVentureHanmi Pharmaceutical Company LimitedTerminatedAdenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung Stage IIIBKorea, Republic of
-
Spectrum Pharmaceuticals, IncTerminated
-
Hanmi Pharmaceutical Company LimitedTerminatedNSCLCKorea, Republic of, China
-
Spectrum Pharmaceuticals, IncTerminated
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Spectrum Pharmaceuticals, IncActive, not recruitingEGFR Exon 20 Mutation | ERBB2 Gene Mutation | Recurrent Lung Non-Small Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States
-
Spectrum Pharmaceuticals, IncTerminatedNSCLCUnited States, Canada, Netherlands, Belgium, Israel, Spain, France, Italy
-
National OncoVentureHanmi Pharmaceutical Company LimitedCompletedIncreased Drug ResistanceKorea, Republic of
-
Avistone Biotechnology Co., Ltd.RecruitingNon-Small-Cell Lung CancerChina
-
Beijing Pearl Biotechnology Limited Liability CompanyCompleted
-
Beijing Pearl Biotechnology Limited Liability CompanyCompletedNon-Small Cell Lung CancerChina
-
Beijing Pearl Biotechnology Limited Liability CompanyRecruitingNon-small Cell Lung CancerChina
-
Hanmi Pharmaceutical Company LimitedNational OncoVentureCompletedHER-2 Positive Advanced Gastric CancerKorea, Republic of
-
Spectrum Pharmaceuticals, IncSuspended
-
Apollomics Inc.Recruiting
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Neelesh Sharma MD PhDCompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Spectrum Pharmaceuticals, IncTerminatedBreast CancerUnited States
-
Xijing Hospital of Digestive DiseasesCompleted
-
Xijing Hospital of Digestive DiseasesCompletedColorectal AdenomasChina
-
Shenyang Sunshine Pharmaceutical Co., LTD.UnknownUremic PruritusChina
-
Galderma R&DCompleted
-
Betta Pharmaceuticals Co., Ltd.Tigermed Consulting Co., LtdCompleted
-
EpygenixCompletedDravet SyndromeUnited States
-
Janssen Research & Development, LLCCompletedSexual Dysfunction, Physiological | EjaculationGermany, Spain, Portugal, Finland, Sweden, Austria
-
Advanz PharmaCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Peking University Third HospitalNot yet recruitingNon-Small Cell Lung Cancer
-
WPD Pharmaceuticals Sp. z o.o.Worldwide Clinical TrialsNot yet recruiting
-
PhytoHealth CorporationCompleted
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsTerminatedHepatocellular CarcinomaChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
National Institute of Allergy and Infectious Diseases...International Tuberculosis Research CenterWithdrawnRefractory Pulmonary TuberculosisKorea, Republic of
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BioCryst PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAnlotinib | Sarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound ComplicationsChina
-
WPD Pharmaceuticals Sp. z o.o.National Center for Research and Development, Poland; Worldwide Clinical TrialsRecruitingRecurrent Glioblastoma MultiformePoland